Misleading meta-analysis

BMJ

Volumn 310, Issue 6982, 1995, Pages 752-

  Egger, Matthias ^a   Smith, George Davey ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE EARTH METAL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC FACTOR; MAGNESIUM; STREPTOKINASE;

CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; MEDICAL LITERATURE; META ANALYSIS; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; PUBLISHING; SECONDARY PREVENTION; STATISTICAL ANALYSIS;

CLINICAL TRIALS; HUMAN; MAGNESIUM; META-ANALYSIS; MYOCARDIAL INFARCTION; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; STREPTOKINASE; SUPPORT, NON-U.S. GOV'T;

EID: 0028964587     PISSN: 09598138     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.310.6982.752     Document Type: Editorial

References (22)

1. Antman EM Lau J Kupelnick B Mosteller F Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. JAMA 1992; 268: 240–8.
2. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; i: 397–402.
3. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii: 349–60.
4. Yusuf S Koon T Woods K. Intravenous magnesium in acute myocardial infarction. An effective, safe, simple, and inexpensive intervention. Circulation 1993; 87: 2043–6.
5. ISIS-4 Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669–85.
6. Yusuf S Flather M. Magnesium in acute myocardial infarction. BMJ 1995; 310: 751–2.
7. Gotzsche PC. Reference bias in reports of drug trials. BMJ 1987; 295: 654–6.
8. Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ 1992; 305: 15–9.
9. Pereira D Pereira TG Rabacal C Carvalho E Linder J Sieuve Afonso J, et al. Efeito da administracao de S04Mg por via intra-venosa na fase aguda do enfarte do miocardio. Rev Port Cardiol 1990; 9: 205–10.
10. Bertschat F Ising H Gunther T Sorgenfrei J Wollitz M Ibe K. Antiarrythmic effects of magnesium infusions in patients with acute myocardial infarction. Magnesium Bulletin 1989; 11: 155–8.
11. Golf SW Graef V Temme H Mobius T Katz N Roka L, et al. Magnesiumbehandlung Beim akuten Myokardinfarkt—biochemische und klinische Daten. Magnesium Bulletin 1990; 12: 100–5.
12. Thogersen AM Johnson O Wester PO. Effects of magnesium infusion on thrombolytic and non-thrombolytic treated patients with acute myocardial infarction. Int J Cardiol 1993; 39: 13–22.
13. Shechter M Hod H Chouraqui P Kaplinski E Rabinowitz B. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol 1995; 75: 321–3.
14. Thogersen AM Johnson O Wester PO. Effects of intravenous magnesium sulphate in suspected acute myocardial infarction on acute arrythmias and long-term outcome. Int J Cardiol (in press).
15. Yusuf S Collins R MacMahon S Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet 1988; i: 1088–92.
16. Collins R. Antiplatelet agents for IUGR and pre-eclampsia. In: EnkinMWKeirseMJNCRenfrewMJNeilsonJPeds. Pregnancy and childbirth module. Cochrane Database of Systematic Reviews. Disk Issue 3. Oxford: Update Software, 1994. (Review no 04000, 12 March 1994. Published through “Cochrane Updates on Disk.”)
17. CLASP Collaborative Group. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619–29.
18. Chalmers I Dickersin K Chalmers TC. Getting to grips with Archie Cochrane's agenda. BMJ 1992; 305: 786–8.
19. Levy G. Publication bias: its implications for pharmacology. Clin Pharmacol Ther 1992; 52: 115–9.
20. Yusuf S Peto R Lewis J Collins R Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progr Cardiovasc Dis 1985; 17: 335–71.
21. Egger M Davey Smith G Song F Sheldon TA. Making sense of meta-analysis. Pharmaco-epidemiology 1993; 2: 65–72.
22. Egger M Davey Smith G. Magnesium and myocardial infarction. Lancet 1994; 343: 1285.